manilatimes19h
Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline
Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...
legit19h
Pharmacists, Chemists, Sell Medicines at New Rate as FG Gives Waiver For Imports
Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...
Euroapi: Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline
Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9 ...
FierceBiotech22h
Sanofi bounces midstage ILT2 asset back to Biond Biologics after $125M bet
Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...